ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2018

Administration of Intravenous Zoledronic Acid Every 3 Months vs. Annually in β-thalassemia Patients with Low Bone Mineral Density: a Retrospective Comparison of Efficacy.

Hadi Darvishi-Khezri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.